GlobeNewswire 4/14 Adagene Adds Industry Veteran Peter Lebowitz to Scientific and Strategic Advisory Board
GlobeNewswire 4/14 Mestag Therapeutics Selected to Present Targeted LTBR Agonist MST‑0312 in Late‑Breaking Session at A...
GlobeNewswire 4/13 American Kidney Fund Announces 2026 Class of Corporate Members Supporting Work to Fight Kidney Disea...
GlobeNewswire 4/9 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Terns Thera...
GlobeNewswire 4/9 Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim as Chief Medical Officer
GlobeNewswire 4/7 Halper Sadeh LLC is Investigating Whether EWCZ, MKC, TERN are Obtaining Fair Deals for their Shareho...
GlobeNewswire 4/7 Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer...
GlobeNewswire 4/7 Arcadia Expands Leadership Team to Redefine AI-Driven Healthcare Performance and Scale into Life Sci...
GlobeNewswire 4/7 Shareholder Alert: Ademi LLP investigates whether Terns Pharmaceuticals Inc. is obtaining a Fair Pri...
GlobeNewswire 4/2 Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination ...
GlobeNewswire 4/2 Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in La...
GlobeNewswire 4/1 Adagene Reports Full Year 2025 Financial Results and Provides Corporate Update
GlobeNewswire 4/1 Akebia Therapeutics Appoints Biopharmaceutical Leader Philip Vickers, Ph.D. to its Board of Director...
GlobeNewswire 4/1 MilliporeSigma Completes Acquisition of JSR Life Sciences’ Chromatography Business, Expanding Protei...
GlobeNewswire 4/1 Merck Completes Acquisition of JSR Life Sciences’ Chromatography Business, Expanding Protein A Capab...
GlobeNewswire 3/31 Proxygen Appoints Chiara Conti, Ph.D. as Chief Scientific Officer to Drive Clinical Translation and ...
GlobeNewswire 3/30 Immix Biopharma Announces Enrollment Completion of BLA-Enabling Relapsed/Refractory AL Amyloidosis T...
GlobeNewswire 3/30 4BIO Capital strengthens investment leadership with appointment of Therese Liechtenstein as Partner ...
GlobeNewswire 3/27 Colorectal Cancer Advocates Urge Congress to Fund New Research
GlobeNewswire 3/26 Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates
GlobeNewswire 3/25 Recursion Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer
TeleTrader 3/25 Merck to buy Terns for $6.7 billion
GlobeNewswire 3/25 Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Nov...
GlobeNewswire 3/24 Transgene Continues Progress to Reshape Early-Stage Cancer Treatment through Individualized Neoantig...
GlobeNewswire 3/24 Quotient Therapeutics Announces Collaboration with Merck to Discover Novel Drug Targets in Inflammat...